標(biāo)題： 1、Intern Med J. 2018 Jan;48 Suppl 1:5-12. doi: 10.1111/imj.13682. Diagnosis and management of hyponatraemia in the older patient. Woodward M1,2, Gonski P3, Grossmann M2, Obeid J4, Scholes R5, Topliss DJ6,7. 2、Heart Fail Clin. 2012 Jan;8(1):33-42. doi: 10.1016/j.hfc.2011.08.013. Volume overload. Carabello BA1. 3、Soriana F ，et al.Comparative susceptility of cefminox and cefotin to β-lactamases of Bacteroides spp J Amimincrob Chem-other 1991;28:55-56 4、Aguilar L,et al.Cefminox correlation between in-vitro susceptibility and pharmacokinetices and serum bactericidal activity in healthy volunteers. J Antimicrob Chemother 1994；33:91-101 5、Torres AJ, et al. Cefminox versus metronidazole plus gentamicin in intra-abdominal infections a prospective randomized controlled clinical trial Infection 2000.28:318-22 6、Ascorbate oxidase: The unexpected involvement of a ‘wasteful enzyme’ in the symbioses with nitrogen-fixing bacteria and arbuscular mycorrhizal fungi 7、Chapter?Twelve:?Integrated?and?Quantitative?Proteomics?of?Human?Tumors 8、 CHSY1?promotes?aggressive?phenotypes?of?hepatocellular?carcinoma?cells?via?activation?of?the?hedgehog?signa ling?pathway 9、 Transporter?expression?in?noncancerous?and?cancerous?liver?tissue?from?subjects?with?hepatocellular?carcinoma?and?chronic?hepatitis?C?in 10、J, Brange,L, Langkjaer.Chemical stability of insulin. 3. Influence of excipients, formulation, and pH.[J].Acta pharmaceutica 要求：將符合標(biāo)題的PDF格式上傳，根據(jù)投稿時間確認稿件，先到先得   [更多]

求購“Gonadotrophin, chorionic”《 EP9.4 》的藥典標(biāo)準(zhǔn)一份.電子版的   [更多]

求購“Sodium Valproate Tablets”《 BP2017 》的藥典標(biāo)準(zhǔn)一份，謝謝。   [更多]

求購“Sodium Valproate Tablets”《 JP17(英) 》的藥典標(biāo)準(zhǔn)一份.謝謝   [更多]

求購“USP Monographs: Buprenorphine and Naloxone Sublingual Tablets”《 USP41-NF36 》的藥典標(biāo)準(zhǔn)。要求清晰電子版一份。   [更多]

求購“Polymyxin B Sulfate”《 BP2017 》《EP9.0》的藥典標(biāo)準(zhǔn)各一份.   [更多]

求期刊DOF（Drugs of the future）2017年第10期的文章   [更多]

標(biāo)題： 1.Pharmacokinetics of a Single 150-mg Intravenous Infusion of Fosaprepitant: Effects of Concentration and Infusion Time in Healthy Japanese Men 作者：Azuma, Junichi 1;Fukase, Hiroyuki 2 刊名：Clinical Pharmacology in Drug Development 出版日期：2013 期號：No.4 卷號：Vol.2 2.Pharmacokinetic evaluation of fosaprepitant dimeglumine 作者：Colon-Gonzalez F;Kraft WK. 刊名：Expert Opinion on Drug Metabolism and Toxicology 出版日期：2010 期號：No.10 卷號：Vol.6 3.Pharmacokinetics of Oral Dexamethasone and Midazolam When Administered With Single-Dose Intravenous 150 mg Fosaprepitant in Healthy Adult Subjects 作者：Dr Thomas C. Marbury MD1,*;Ms Phung L. Ngo MS2;Mr Craig R. Shadle MS2;Dr Bo Jin PhD2;Ms Deborah Panebianco MS2;Dr Luzelena Caro PhD2;Dr Jack Valentine PhD2,3;Dr Gail Murphy MD2 刊名：J Clin Pharmacol 出版日期：2011 卷號：Vol.51 4.A Single-Dose Bioequivalence and Food Effect Study With Aprepitant and Fosaprepitant Dimeglumine in Healthy Young Adult Subjects 作者：Craig R. Shadle1,*;M. Gail Murphy1;Yang Liu2;Maureen Ho1;Daniel Tatosian3;Susie (Xiujiang) Li3;Robert A. Blum4 刊名：Clinical Pharmacology in Drug Development 出版日期：2012 期號：No.3 卷號：Vol.1 5.Clinical pharmacology of neurokinin-1 receptor antagonists for the treatment of nausea and vomiting associated with chemotherapy 作者：Bernardo Rapoport;Teresa Smit 刊名：Expert Opinion on Drug Safety 6.Aprepitant and Fosaprepitant Drug Interactions: A Systematic Review. 作者：Patel P;Leeder JS;Piquette-Miller M;Dupuis LL. 刊名：Br J Clin Pharmacol 出版日期：2017 7.Tolerability of fosaprepitant and bioequivalency to aprepitant in healthy subjects. 作者：Dr Kenneth C. Lasseter MD1,*;Dr Jay Gambale PharmD2;Dr Bo Jin PhD2;Dr Art Bergman PhD2;Mr Marvin Constanzer MS2;Mr James Dru MS2;Dr Tae H. Han PhD2;Dr Anup Majumdar PhD2;Dr Judith K. Evans MD2;Dr M. Gail Murphy MD2 刊名：The Journal of Clinical Pharmacology 出版日期：2007 期號：NO.7 卷號：Vol.47 8.Prevention of chemotherapy-induced nausea and vomiting:focus on fosaprepitant 作者：Ian N Olver 刊名：Ther Clin Risk Manag 出版日期：2008 期號：No.2 卷號：Vol.4   [更多]

急需“Sertraline hydrochloride”《 EP9.4 》的藥典標(biāo)準(zhǔn)一份.謝謝   [更多]

標(biāo)題： 1、Comparative Pharmacokinetics of the New Oral Cephalosporins 2、Jiang X, Wang N, Zhang Z J, et al. Pharmacokinetics and comparative bioavailability of two terbinafine hydrochloride formulations after single-dose administration in Chinese healthy subjects.[J]. Arzneimittel-Forschung, 2008, 58(7):363-366. 3、Almeida S, Filipe A, Vallée F, et al. Comparative bioavailability of two formulations of terbinafine. Data from a cross-over, randomised, open-label bioequivalence study in healthy volunteers.[J]. Arzneimittel-Forschung, 2004, 54(11):757-62. 4、De-Oliveira C, Barrientos-Astigarraga R, De-Moraes M, et al. Terbinafine quantification in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry: application to a bioequivalence study.[J]. Therapeutic Drug Monitoring, 2001, 23(6):709. 5、Impact of moisture and magnesium stearate functionality on manufacturability of wet granulated metformin tablets 6、The?antipruritic?effect?of?5%?doxepin?cream?in?patients?with?eczematousdermatitis.?Doxepin?Study Group. 7、Photoisomerization of Ionic Liquid Ammonium Cinnamates: One-Pot Synthesis?Isolation of Z-Cinnamic Acids 8、[Pharmacokinetics and bioequivalence of atorvastatin calcium tablets in healthy male Chinese volunteers]. 9、Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Lowering With Atorvastatin in Patients of South Asian Compared With European Origin: Insights From the Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration (ACTFAST) Study 10、Do the lipid responses to rosuvastatin and atorvastatin differ between Chinese and Caucasians? Comparison of the DISCOVERY-Hong Kong study with other DISCOVERY studies 備注：將符合的文獻PDF格式打包上傳   [更多]